Accessibility Menu
 

Neurobiological Technologies

(OTC) NTII

Current Price$0.00
Market CapN/A
Since IPO (1994)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Neurobiological Technologies Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$28.81M

Net Income (TTM)

$11.29M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

583.34 (High)

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

NTII News

No articles available.

NTII: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Neurobiological Technologies

Industry

Biotechnology

Headquarters

EmeryVille, CA 94608, US

NTII Financials

Key Financial Metrics (TTM)

Gross Margin

99%

Operating Margin

13%

Net Income Margin

12%

Return on Equity

0%

Return on Capital

1%

Return on Assets

1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

27.02M

Volume

1.00K

Short Interest

0.00%

Avg. Volume

16.667

Financials (TTM)

Gross Profit

$26.22M

Operating Income

$3.49M

EBITDA

$3.25M

Operating Cash Flow

$16.43M

Capital Expenditure

$2.00K

Free Cash Flow

$16.43M

Cash & ST Invst.

$2.58M

Total Debt

$0.00

Neurobiological Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2009YOY CHG

Revenue

$6.03M

+69.0%

Gross Profit

$6.03M

+69.0%

Gross Margin

100.00%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

4

N/A

Net Income

$5.41M

+295.7%

EBITDA

$5.16M

+262.9%

Quarterly Fundamentals

Name
Q1 2009YOY CHG

Net Cash

$26.49M

-6.0%

Accounts Receivable

$3.00M

+1530.4%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

1.21%

N/A

Return on Invested Capital

1.39%

N/A

Free Cash Flow

$2.36M

+178.2%

Operating Cash Flow

$2.36M

+178.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANTHAnthera Pharmaceuticals, Inc.
$0.00+0.00%
GBIMGlobeImmune, Inc.
$0.00+0.00%
SYVCSynovics Pharmaceuticals, Inc.
$0.00+0.00%
OVITOncoVista Innovative Therapies, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%

Questions About NTII

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.